DBD stock: buy or sell?
August 23rd, 2019
Diebold Nixdorf, Incorporated provides connected commerce services, software, and technology for financial, commercial, and industrial customers.
Should I buy DBD stock?You can't be a successful trader if you don't follow a methodolgy or system that assist you in choosing companies and the correct market timing. Following a trading plan helps to make decisions easier, quicker and with less hesitations. At Stocks2.com, we use very simple but trusted and powerful trend following trading strategies. Simple things usually work the best.
None of our preferred buy setups matches with Diebold Nixdorf stock situation right now, therefore this is not a suitable entry point.
|New all-time high||No|
|New 52 week high||No|
|Price crossing up 200d MA||No|
|100d MA crossing up 200d MA||No|
Is Diebold Nixdorf stock a buy?
Banks and financial institutions publish stock ratings everyday.At Stocks2.com, we found 1 rating published for DBD stock in the last month.
|Date||Analyst / Broker||Previous rating||Current rating|
|2019-2-14||JPMorgan Chase & Co.||n/a||Sell|
DBD stock analysis
Diebold Nixdorf closed today at $11.58 and plummed a scary -7.66%.
Diebold Nixdorf shares plummed -7.66% to $11.58 today. Since April when SMA100d and SMA200d crossed up, DBD price slipped $-0.95 per share (-7.58%). Since July 25th when DBD stock price broke up the SMA100d line, it gained $1.29 (12.54%).
Diebold Nixdorf collapsed a scary -7.29% this week. Early August DBD boosted an extraordinary 6.06% in just one week.
In a weekly time frame, Diebold Nixdorf stock is drawing an uptrend with rising tops and bottoms. Now trading in between its last bottom and last top, DBD might consolidate in a flat-base, waiting to break out over or down under . Since SMA20d and SMA40w crossed up early April, DBD price climbed $0.51 per share (4.61%). Since mid February when DBD stock price broke up the SMA40w line, it gained $6.57 (131.14%).
DBD stock price history
DBD IPO was on December 31st, 1981 at $2.07 per share1. Since then, DBD stock surged a 459.40%, with a yearly average of 12.40%. If you had invested $1,000 in DBD stock in 1981, it would worth $4,594.00 today.
1: Adjusted price after possible price splits or reverse-splits.
DBD stock historical price chart
DBD stock reached 52-week highs on July 31st at $14.66, and all-time highs 2005-04-07 with a price of 38.51.
DBD stock price target is $7.00How much a stock will be priced tomorrow or next week is quite unpredictable However, many stock price predictions are published every day by banks, financial institutions and independent analysts. The accuracy of these stock price predictions is not very high, and you should not blindly believe and make decisions only based on what this ratings or price target predictions say. For the last month we only found 1 price prediction for Diebold Nixdorf stock:
|Date||Analyst / Broker||Action||Previous target||Current target||Diff|
|2019-2-14||JPMorgan Chase & Co.||Set Price Target||n/a||$7.00||-|
Financials and fundamental analysis
Earnings date and Earnings per ShareAfter publishing its last earnings report on February, Diebold Nixdorf . As soon as we get its actual EPS from the earnings report, we will update this review.
|Quarter||Reporting date||Estimated EPS||Actual EPS||Surprise|
Annual financial resultsIn 2018, Diebold Nixdorf annual turnover remained steady a bad -0.67% to $4,578.60 million USD from $4,609.30 marked in 2017. When comparing 2018 vs 2017, on the other hand, profit margin (that is, the net income divided by revenues) dropped a -7.18% to -12.42%.
|2013||$2,860 M||-||$-181.61 M-6.3%||-|
|2014||$3,051 M||6.68%||$114 M3.8%||-163.00%|
|2015||$2,419 M||-20.71%||$74 M3.0%||-35.59%|
|2016||$3,316 M||37.08%||$-33.00 M-1.0%||-144.78%|
|2017||$4,609 M||38.99%||$-241.50 M-5.2%||631.82%|
|2018||$4,579 M||-0.67%||$-568.70 M-12.4%||135.49%|
Quarterly financial resultsDiebold Nixdorf reported $1,289.80 million in revenues for 2018-Q4, a 15.26% up compared to previous quarter. Reported quarter earnings marked $-145.50 M with a profit margin of -11.28%. Profit margin escalated a 7.72% compared to previous quarter when profit margin was -19.00%. When comparing sales to same quarter last year, Diebold Nixdorf sales marked a beatiful growth and raised a 3.19%. Looking back to recent quarterly results, Diebold Nixdorf posted 3 negative quarters in a row.
|2017-Q2||$1,130 M||-||$-30.60 M-2.7%||-|
|2017-Q3||$1,123 M||-0.65%||$-35.40 M-3.2%||15.69%|
|2017-Q4||$1,250 M||11.33%||$-106.40 M-8.5%||200.56%|
|2018-Q1||$1,064 M||-14.86%||$-70.90 M-6.7%||-33.36%|
|2018-Q2||$1,106 M||3.89%||$-138.50 M-12.5%||95.35%|
|2018-Q3||$1,119 M||1.21%||$-212.60 M-19.0%||53.50%|
|2018-Q4||$1,290 M||15.26%||$-145.50 M-11.3%||-31.56%|
|2019-Q1||$1,028 M||-20.29%||$-132.70 M-12.9%||-8.80%|
Diebold Nixdorf ownershipWhen you are planning to buy a stock, it's always worth to check its ownership structure.
Diebold Nixdorf shares owned by insiders (that is, founders, CEO, CTO, main executives or other management staff) currently counts a 2.39% of all shares.
Bearish positions for DBD stock account 0.00%, no big difference from last month.
For a better context understanding, the following table shows ownership data compared to other related companies:
|Market cap||$886.9 M||$3.6 B||$3.7 B||$356.7 M||$652.4 M|
|Total shares||76.6 M||49.9 M||120.1 M||16.3 M||180.7 M|
|Float shares||75.8 M||48.6 M||119.4 M||8.7 M||179.3 M|
|- Institutional holdings (%)||99.2%||105.1%||98.8%||59.5%||74.1%|
|- Insider holdings (%)||2.4%||1.1%||1.3%||33.8%||0.5%|
|Shares in short selling||0.0%||0.0%||0.0%||0.0%||0.0%|
|Friday, August 23rd, 2019|
|Day range||$11.47 - $12.74|
|Average true range||$0.75|
|50d mov avg||$11.00|
|100d mov avg||$10.85|
|200d mov avg||$8.28|
Diebold Nixdorf performanceTo better understand Diebold Nixdorf performance you must becnhmark its gains with other related stocks in same sector or industry. We compared Diebold Nixdorf against Brink's, NCR, PAR Technology, Pitney Bowes and USA Technologies in the following table: